| NAME |
STSM TITLE |
REFERENCE |
DATE |
LOCATION |
HOST |
| Mr Alejandro Escobar – a.escobar@iqog.csic.es |
Design and synthesis of fluorinated Keap1 inhibitors for setting up 19F-based NMR screening assays and finding novel neuroprotective compounds. |
ECOST-STSM-CA15135-171016-081125 |
from 17-10-2016 to 13-01-2017 |
Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark |
Prof Anders Bach – anders.bach@sund.ku.dk |
| Dr Carmen Festa – carmen.festa@unina.it |
Computer-aided drug design of multi-target ligands of bile acid receptors for the treatment of metabolic disorders. |
ECOST-STSM-CA15135-011116-081126 |
from 01-11-2016 to 01-02-2017 |
Institute of Computational Science, Faculty of Informatics, Università della Svizzera Italiana (USI), Lugano, Switzerland |
Prof Vittorio Limongelli – vittoriolimongelli@gmail.com |
| Dr Luis Emiliano Pena Altamira – luis.penaaltamira3@unibo.it |
Development of multi-target directed ligands with a neuroprotective and neuroregenerative mechanism of action. |
ECOST-STSM-CA15135-211116-081088 |
from 21-11-2016 to 16-12-2016 |
Spanish Council for Research, Biological Research Center, Madrid, Spain |
Dr Ana Martinez – ana.martinez@csic.es |
| Dr Ziga Jakopin |
Dual NOD1/NOD2 antagonists as immunomodulatory agents |
ECOST-STSM-CA15135-36021 |
from 09/01/2017 to 19/04/2017 |
University of Milan, Faculty of Pharmacy, Department of Pharmacological and Biomolecular Sciences, Laboratory of Toxicology, IT |
Prof Emanuela Corsini – emanuela.corsini@unimi.it |
| MsLejlaHalilovic |
Combinatorial treatment of Non-Hodgkin’s lymphomas with Metformin and Thymoquinone |
ECOST-STSM-CA15135-36100 |
from 25/01/2017 to 25/02/2017 |
Institute of Oncology Research, CH |
Dr Eugenio Gaudio – eugenio.gaudio@ior.iosi.ch |
| MsFilipaRamilo-Gomes |
A multi-target approach to anticancer therapy: Design of novel epigenetic inhibitors. |
ECOST-STSM-CA15135-36268 |
from 30/01/2017 to 03/03/2017 |
InteLigand Software Entwicklungs und Consulting, AT |
DrSharon Bryant – bryant@inteligand.com |
| Dr Eva Mezeiova |
N-propargyl-naphthoquinone hybrids: New disease-modifying agents for Alzheimer’s disease |
ECOST-STSM-CA15135-35172 |
from 30/01/2017 to 28/04/2017 |
Laboratory of Medicinal Chemistry, Institute of Organic Chemistry of Madrid, National Research Council, ES |
Prof Jose Marco-Contelles, – iqoc21@iqog.csic.es |
| MsAgnieszkaOlejarz |
Dual-target ligands for the orphan G protein-coupled receptors GPR18/GPR55 for immune modulationand cancere |
COST-STSM-CA15135-35207 |
from 01/03/2017 to 30/04/2017 |
University of Bonn Pharmaceutical Institute Pharmaceutical Chemistry I, DE |
Prof Christa Müller, -christa.mueller@uni-bonn.de |
